(26 May 2017, Minneapolis, MN, USA and Oxford, UK) Open Therapeutics and INASP’s AuthorAID project announce the formation of a unique scientific collaboration service for helping underserved scientists around the world communicate break-through therapeutic biotechnology research. The partnership will provide scientific researchers an ability to conduct or receive mentorship, educational materials, and grant funding.
AuthorAID is a pioneering global network that provides support, mentoring, resources and training for researchers from low and middle income countries. The programme supports over 16,000 researchers to publish and communicate their work by providing free access to mentoring, online courses in research and proposal writing, training resources, and a global network of supporters.
Open Therapeutics helps underserved researchers around the world gain scientific collaborators. This is done by crowdsourcing the researchers around open therapeutic biotechnologies within its free web-based collaboration platform, Therapoid™.
According to Jason E. Barkeloo, Founder and Executive Chairman of Open Therapeutics, “AuthorAID has a proven ability to deliver a mentorship and educational programme to underserved scientists. We are proud to offer the AuthorAID programme to collaborating scientists within Therapoid. We are also excited to help the researchers within Therapoid learn about communicating their scientific findings to other researchers, journals, and grant funders.”
Jennifer Chapin, AuthorAID Programme Manager at INASP, outlines how AuthorAID and Open Therapeutics complement each other: “We are looking forward to connecting our researchers with the innovative offers on the Therapoid platform, and we know that this partnership will create a richer breadth of services for researchers from developing countries looking to build skills, publish and progress in their careers.”
About Open Therapeutics LLC
Open Therapeutics (OpenTherapeutics.org) is a crowdsourcing life science firm that creates and attracts therapeutic biotechnologies and crowdsources them for the global scientific community. The global research community can freely access the biotechnologies and funding to further the development of the biotechnologies at Therapoid™ (https://Therapoid.net). The Company is headquartered in Minneapolis, MN, with laboratory operations in Covington, Kentucky, Cincinnati, OH, Amman, Jordan, and Bangalore, India.
The announcement in full is here.
